DOCSLIB.ORG

MODURETIC® Amiloride Hydrochloride 5 Mg/Hydrochlorothiazide 50 Mg Consumer Medicine Information (CMI)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
MODURETIC® Amiloride Hydrochloride 5 Mg/Hydrochlorothiazide 50 Mg Consumer Medicine Information (CMI) MODURETIC® amiloride hydrochloride 5 mg/hydrochlorothiazide 50 mg Consumer Medicine information (CMI) What is in this leaflet around your body. Your blood pressure may be different at different times of the day, depending on how This leaflet answers some common Before you take it questions about MODURETIC. It busy or worried you are. You have does not contain all the available hypertension or high blood pressure information. when your blood pressure stays When you must not take it higher than is needed, even when you Do not take MODURETIC if you It does not take the place of talking to are calm and relaxed. your doctor or pharmacist. have ever had an allergic reaction There are usually no symptoms of to: All medicines have risks and hypertension. The only way of benefits. Your doctor has weighed amiloride hydrochloride knowing that you have hypertension the risks of you taking is to have your blood pressure hydrochlorothiazide, sulfonamide MODURETIC against the benefits checked on a regular basis. If high or sulfur medicines they expect it will have for you. blood pressure is not treated it can Hydrochlorothiazide is a sulfur- If you have any concerns about lead to serious health problems. You containing medicine (a taking this medicine, ask your may feel fine and have no symptoms, sulfonamide). Therefore, if you doctor or pharmacist. but eventually hypertension can are allergic to sulfur medicines, Keep this leaflet with the medicine. cause stroke, heart disease and such as some antibiotics, you are kidney failure. likely to be allergic to You may need to read it again. The combination of active MODURETIC. ingredients in MODURETIC work Check with your doctor or by making your kidneys pass more pharmacist if you are not sure What MODURETIC is water and salt whilst minimizing whether you are allergic to used for potassium loss. This helps reduce sulfur medicines. high blood pressure and some forms any of the ingredients listed at the of swelling, while at the same time MODURETIC contains a end of this leaflet. helping to maintain normal levels of combination of two diuretics, Symptoms of an allergic reaction amiloride hydrochloride and potassium in your blood. may include shortness of breath, Ask your doctor if you have any hydrochlorothiazide as the active wheezing or difficulty in breathing; ingredients. questions about why this medicine swelling of the face, lips, tongue or has been prescribed for you. MODURETIC is used to help reduce any other parts of the body; rash, the amount of excess fluid in the Your doctor may have prescribed it itching or hives on the skin. body for people who have: for another purpose. Do not take MODURETIC if you oedema, swelling of the ankles, This medicine is only available with are pregnant or intend to become feet and legs a doctor's prescription. pregnant unless you and your ascites due to liver disease There is no evidence that it is doctor have discussed the risks and resulting in fluid accumulation in addictive. benefits involved. the stomach area. It may affect your developing baby if MODURETIC is also used to help you take it during pregnancy. people with hypertension or high Do not take MODURETIC if you blood pressure. are breast-feeding or intend to Everyone has blood pressure. This breast-feed. pressure helps get your blood all MODURETIC® 1 This medicine can pass into breast Taking other medicines Your doctor or pharmacist has more milk and therefore may harm the information on medicines to be Tell your doctor if you are taking baby. careful with or to avoid while taking any other medicines, including MODURETIC. Do not take MODURETIC if: medicines that you buy without a you have kidney disease prescription from your pharmacy, supermarket or health food shop. your doctor advises you that you have too much potassium in your Some medicines and MODURETIC How to take it blood may interfere with each other. These include: you are taking medicines which How much to take can increase the amount of potassium tablets or other Your doctor will tell you how many potassium in the blood or you are potassium-conserving medicines tablets you need to take each day. eating a potassium-rich diet. ACE inhibitors, medicines used This depends on your condition and MODURETIC helps maintain to treat high blood pressure whether you are taking other normal levels of potassium in other medicines used to treat high medicines. Your initial dose will be your blood. If you are taking blood pressure maintained or adjusted until a potassium tablets or supplements, other fluid tablets (diuretics) other potassium-conserving satisfactory response is noted, but should not exceed 4 tablets per day. medicines or a potassium-rich digoxin, used to treat heart failure diet, your potassium levels may lithium, used to treat severe mood Follow all directions given to you increase too much. swings and some types of by your doctor and pharmacist carefully. Ask your doctor or pharmacist depression if you are not sure whether you non-steroidal anti-inflammatory They may differ from the are taking any of these. medicines (NSAIDs), used to information contained in this leaflet. Do not give MODURETIC to a treat inflammation, pain and When to take it child. arthritis The safety of MODURETIC in steroid medicines such as If you are taking a single dose a children has not been established. cortisone, prednisone day, take it in the morning. If you are taking more than one dose a Do not take MODURETIC if the insulin and tablets used to treat day, take the last dose in the early packaging is torn or shows signs of diabetes evening, unless your doctor tells tampering. cyclosporin and tacrolimus, you otherwise. Do not take this medicine after the medicines used to suppress the MODURETIC may increase the expiry date printed on the pack. immune system amount of urine you pass and the barbiturates, used to treat number of times you go to the toilet. Before you start to take it epilepsy, such as phenobarbitone By taking the last dose in the early Tell your doctor if you are allergic strong pain killers such as evening there may be less chance of to any other medicines or any codeine, morphine, your sleep being disturbed. foods, dyes or preservatives. dextroproxyphene Take MODURETIC at about the Tell your doctor if you have or cholestyramine and colestipol, same time each day, unless your have had any of the following used to treat high cholesterol doctor tells you otherwise. medical conditions: medicines used to relax muscles This will help you remember when to high potassium levels in the blood before and during surgery take the tablets. diabetes medicines used in emergency How long to take it liver disease situations such as adrenaline Continue taking MODURETIC for kidney disease alcohol. as long as your doctor tells you. heart and lung disease These medicines may be affected by MODURETIC or may affect how If you have high blood pressure, this high cholesterol well it works. You may need to take medicine helps to control this gout different amounts of your medicine, condition but does not cure it. asthma or you may need to take different Therefore MODURETIC must be medicines. taken every day. lupus erythematosus. MODURETIC® 2 If you have oedema or ascites, your dentist that you are taking Talk to your doctor or pharmacist doctor will tell you how long to take MODURETIC. about these measures and for more it. Tell any other doctor, dentist of information. pharmacist who is treating you Alcohol If you forget to take it that you are taking MODURETIC, your doctor may advise you to If it is almost time for your next especially if you are about to be limit your alcohol intake. dose, skip the dose you missed and started on any new medicines. Diet take your next dose when you are Tell your doctor if you become eat a healthy diet which includes meant to. Otherwise, take it as pregnant while taking plenty of fresh vegetables, fruit, soon as you remember and then go MODURETIC. back to taking your medicine as bread, cereals and fish. Also eat you would normally. Things to be careful of less fat and sugar. Exercise Do not take a double dose to make Be careful driving or operating up for the dose that you missed. machinery until you know how this regular exercise helps to reduce medicine affects you. blood pressure. Try regular If you take too much walking, swimming, cycling or MODURETIC may cause dizziness (overdose) games such as tennis and golf. or light-headedness in some people, Before starting any exercise, ask Immediately telephone your doctor especially after the first few doses or your doctor about the best kind of or Poisons Information Centre on if the dose is increased. Make sure programme for you. 13 11 26 (Australia) or 0800 you know how you react to it before POISON or 0800 764 766 (New you drive a car, operate machinery or Salt Zealand) for advice, or go to do anything else that could be your doctor may advise you to Accident and Emergency at your dangerous if you are dizzy or light- watch the amount of salt in your nearest hospital, if you think that headed. diet. To reduce your salt intake you or anyone else may have taken If you drink alcohol, or take strong you should avoid using salt in too much MODURETIC. Do this pain killers or barbiturates, dizziness cooking or at the table. even if there are no signs of and light-headedness may be worse. Smoking discomfort or poisoning.
Load more

Recommended publications
  • SPIRONOLACTONE Spironolactone – Oral (Common Brand Name
    SPIRONOLACTONE Spironolactone – oral (common brand name: Aldactone) Uses: Spironolactone is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (e.g., congestive heart failure) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat low potassium levels and conditions in which the body is making too much of a natural chemical (aldosterone). Spironolactone is known as a “water pill” (potassium-sparing diuretic). Other uses: This medication has also been used to treat acne in women, female pattern hair loss, and excessive hair growth (hirsutism), especially in women with polycystic ovary disease. Side effects: Drowsiness, lightheadedness, stomach upset, diarrhea, nausea, vomiting, or headache may occur. To minimize lightheadedness, get up slowly when rising from a seated or lying position. If any of these effects persist or worsen, notify your doctor promptly. Tell your doctor immediately if any of these unlikely but serious side effects occur; dizziness, increased thirst, change in the amount of urine, mental/mood chances, unusual fatigue/weakness, muscle spasms, menstrual period changes, sexual function problems. This medication may lead to high levels of potassium, especially in patients with kidney problems. If not treated, very high potassium levels can be fatal. Tell your doctor immediately if you notice any of the following unlikely but serious side effects: slow/irregular heartbeat, muscle weakness. Precautions: Before taking spironolactone, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies.
    [Show full text]
  • Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy Using Machine Learning
    Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy using Machine Learning Kate Wang et al. Supplemental Table S1. Drugs selected by Pharmacophore-based, ML-based and DL- based search in the FDA-approved drugs database Pharmacophore WEKA TF 1-Palmitoyl-2-oleoyl-sn-glycero-3- 5-O-phosphono-alpha-D- (phospho-rac-(1-glycerol)) ribofuranosyl diphosphate Acarbose Amikacin Acetylcarnitine Acetarsol Arbutamine Acetylcholine Adenosine Aldehydo-N-Acetyl-D- Benserazide Acyclovir Glucosamine Bisoprolol Adefovir dipivoxil Alendronic acid Brivudine Alfentanil Alginic acid Cefamandole Alitretinoin alpha-Arbutin Cefdinir Azithromycin Amikacin Cefixime Balsalazide Amiloride Cefonicid Bethanechol Arbutin Ceforanide Bicalutamide Ascorbic acid calcium salt Cefotetan Calcium glubionate Auranofin Ceftibuten Cangrelor Azacitidine Ceftolozane Capecitabine Benserazide Cerivastatin Carbamoylcholine Besifloxacin Chlortetracycline Carisoprodol beta-L-fructofuranose Cilastatin Chlorobutanol Bictegravir Citicoline Cidofovir Bismuth subgallate Cladribine Clodronic acid Bleomycin Clarithromycin Colistimethate Bortezomib Clindamycin Cyclandelate Bromotheophylline Clofarabine Dexpanthenol Calcium threonate Cromoglicic acid Edoxudine Capecitabine Demeclocycline Elbasvir Capreomycin Diaminopropanol tetraacetic acid Erdosteine Carbidopa Diazolidinylurea Ethchlorvynol Carbocisteine Dibekacin Ethinamate Carboplatin Dinoprostone Famotidine Cefotetan Dipyridamole Fidaxomicin Chlormerodrin Doripenem Flavin adenine dinucleotide
    [Show full text]
  • Exforge HCT in Patients with These Highlights Do Not Include All the Information Needed to Use Diabetes (4) EXFORGE HCT Safely and Effectively
    HIGHLIGHTS OF PRESCRIBING INFORMATION Do not coadminister aliskiren with Exforge HCT in patients with These highlights do not include all the information needed to use diabetes (4) EXFORGE HCT safely and effectively. See full prescribing information for EXFORGE HCT. -----------------------WARNINGS AND PRECAUTIONS ----------------------- Hypotension: Correct volume depletion prior to initiation (5.2) ® EXFORGE HCT (amlodipine, valsartan, and hydrochlorothiazide) Increased angina and/or myocardial infarction (5.3) tablets, for oral use Monitor renal function and potassium in susceptible patients (5.4, 5.5) Initial U.S. Approval: 2009 Exacerbation or activation of systemic lupus erythematosus (5.7) WARNING: FETAL TOXICITY Observe for signs of fluid or electrolyte imbalance (5.9) See full prescribing information for complete boxed warning. Acute angle-closure glaucoma (5.10) When pregnancy is detected, discontinue Exforge HCT as soon as possible. (5.1) ------------------------------ADVERSE REACTIONS ------------------------------ Drugs that act directly on the renin-angiotensin system can cause Most common adverse events (≥ 2% incidence) are dizziness, peripheral injury and death to the developing fetus. (5.1) edema, headache, dyspepsia, fatigue, muscle spasms, back pain, nausea, and nasopharyngitis. (6.1) ---------------------------INDICATIONS AND USAGE --------------------------- Exforge HCT is a combination tablet of amlodipine, a dihydropyridine To report SUSPECTED ADVERSE REACTIONS, contact Novartis calcium channel blocker (DHP CCB), valsartan, an angiotensin II receptor Pharmaceuticals Corporation at 1-888-669-6682 or FDA at 1-800-FDA- blocker (ARB), and hydrochlorothiazide, a thiazide diuretic. Exforge HCT is 1088 or www.fda.gov/medwatch. indicated for the treatment of hypertension to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, ------------------------------DRUG INTERACTIONS ------------------------------ primarily strokes, and myocardial infarctions.
    [Show full text]
  • Karger AG, Basel Published Online: November 26, 2018 by S
    Neurosignals 2018;26:77-93 DOI: 10.1159/000495425 © 2018 The Author(s).© 2018 Published The Author(s) by S. Karger AG, Basel Published online: November 26, 2018 www.karger.com/nsgPublished by S. Karger AG, Basel 77 www.karger.com/nsg Accepted:Hundehege November et al.: Pregabalin 08, 2018 in Experimental Autoimmune Encephalitis This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Original Paper Targeting Voltage-Dependent Calcium Channels with Pregabalin Exerts a Direct Neuroprotective Effect in an Animal Model of Multiple Sclerosis Petra Hundehegea Juncal Fernandez-Ortha Pia Römera Tobias Rucka Thomas Münteferinga Susann Eichlera Manuela Cerinaa Lisa Eppinga Sarah Albrechta Amélie F. Menkea Katharina Birknerb Kerstin Göbela Thomas Buddec Frauke Zippb Heinz Wiendla Ali Gorjid Stefan Bittnerb Sven G. Meutha aNeurology Department with Institute of Translational Neurology, University of Münster, bDepartment of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, cInstitute of Physiology I, University of Münster, dNeurology Department with Institute of Translational Neurology and Neurosurgery Department, University of Münster, Germany Key Words Multiple sclerosis • Pregabalin • Experimental autoimmune encephalomyelitis • Neuroprotection Abstract Background/Aims: Multiple sclerosis (MS) is a prototypical autoimmune central nervous system (CNS) disease. Particularly progressive forms of MS (PMS) show significant neuroaxonal damage as consequence of demyelination and neuronal hyperexcitation. Immuno-modulatory treatment strategies are beneficial in relapsing MS (RMS), but mostly fail in PMS.
    [Show full text]
  • AMILORIDE HYDROCHLORIDE and HYDROCHLOROTHIAZIDE- Amiloride Hydrochloride and Hydrochlorothiazide Tablet Mylan Pharmaceuticals Inc
    AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE- amiloride hydrochloride and hydrochlorothiazide tablet Mylan Pharmaceuticals Inc. ---------- DESCRIPTION Amiloride hydrochloride and hydrochlorothiazide tablets, USP combine the potassium- conserving action of amiloride hydrochloride with the natriuretic action of hydrochlorothiazide. Amiloride hydrochloride is designated chemically as 3,5-diamino-6-chloro-N-(diamino- methylene)pyrazinecarboxamide monohydrochloride, dihydrate. It has the following structural formula: C6H8ClN7O•HCl•2H2O MW = 302.12 Hydrochlorothiazide is designated chemically as 6-chloro-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide. It has the following structural formula: C7H8ClN3O4S2 MW = 297.74 It is a white, or practically white, crystalline powder which is slightly soluble in water, but freely soluble in sodium hydroxide solution. Each tablet, for oral administration, contains 5 mg of amiloride hydrochloride, USP (calculated on the anhydrous basis) and 50 mg of hydrochlorothiazide, USP. In addition, each tablet contains the following inactive ingredients: croscarmellose sodium, FD&C Yellow No. 6 Aluminum Lake, lactose monohydrate, magnesium stearate, pregelatinized starch (corn), and sodium lauryl sulfate. CLINICAL PHARMACOLOGY Amiloride hydrochloride and hydrochlorothiazide tablets provide diuretic and antihypertensive activity (principally due to the hydrochlorothiazide component), while acting through the amiloride component to prevent the excessive potassium loss that may occur in patients receiving
    [Show full text]
  • Ambetter 90-Day-Maintenance Drug List- 2020
    Ambetter 90-Day-Maintenance Drug List Guide to this list: What is Ambetter 90‐Day‐Maintenance Drug List? Ambetter 90‐Day‐Supply Maintenance Drug List is a list of maintenance medications that are available for 90 day supply through mail order or through our Extended Day Supply Network. How do I find a pharmacy that is participating in Extended Day Supply Network? To find a retail pharmacy that is participating in our Extended Day Supply Network please consult information available under Pharmacy Resources tab on our webpage. Alternatively, you can utilize our mail order pharmacy. Information on mail order pharmacy is available in Pharmacy Resources tab on our webpage. Are all formulary drugs covered for 90 day supply? No, certain specialty and non‐specialty drugs are excluded from 90 day supply. Please consult 90‐Day‐ Supply Maintenance Drug List for information if your drug is included. A Amitriptyline HCl Acamprosate Calcium Amlodipine Besylate Acarbose Amlodipine Besylate-Atorvastatin Calcium Acebutolol HCl Amlodipine Besylate-Benazepril HCl Acetazolamide Amlodipine Besylate-Olmesartan Medoxomil Albuterol Sulfate Amlodipine Besylate-Valsartan Alendronate Sodium Amlodipine-Valsartan-Hydrochlorothiazide Alendronate Sodium-Cholecalciferol Amoxapine Alfuzosin HCl Amphetamine-Dextroamphetamine Aliskiren Fumarate Anagrelide HCl Allopurinol Anastrozole Alogliptin Benzoate Apixaban Alosetron HCl Arformoterol Tartrate Amantadine HCl Aripiprazole Amiloride & Hydrochlorothiazide Armodafinil Amiloride HCl Asenapine Maleate Amiodarone HCl Aspirin-Dipyridamole
    [Show full text]
  • FDA's) Current Thinking on This Topic
    Contains Nonbinding Recommendations Draft Guidance on Amiloride Hydrochloride This draft guidance, once finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the Office of Generic Drugs. Active ingredient: Amiloride Hydrochloride Form/Route: Tablet; Oral Recommended studies: 2 Studies 1. Type of study: Fasting Design: Single-dose, two-way crossover in-vivo Strength: EQ 5 mg Base Subjects: Healthy males, nonpregnant females and non-elderly, general population. Additional Comments: Subjects with impaired renal function, diabetes mellitus, should be excluded from the study. As amiloride treatment may cause hyperkalemia, serum potassium levels should be monitored carefully during the bioequivalence study. ________________________________________________________________________ 2. Type of study: Fed Design: Single-dose, two-way crossover in-vivo Strength: EQ 5 mg Base Subjects: Healthy males, nonpregnant females and non-elderly, general population. Additional Comments: Please see above. ________________________________________________________________________ Analytes to measure (in appropriate biological fluid): Amiloride in plasma Bioequivalence based on (90% CI): Amiloride Waiver request of in-vivo testing: Not applicable Dissolution test method and sampling times: Please note that a Dissolution Methods Database is available to the public at the OGD website at http://www.accessdata.fda.gov/scripts/cder/dissolution/. Please find the dissolution information for this product at this website. Please conduct comparative dissolution testing on 12 dosage units each of all strengths of the test and reference products.
    [Show full text]
  • Investigating Neuroprotectants for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
    THE UNIVERSITY OF NEW SOUTH WALES Translational Neuroscience Facility School of Medical Sciences Faculty of Medicine UNSW Australia A thesis in fulfilment of the requirements for the degree of: Masters Investigating Neuroprotectants for the Treatment of Chemotherapy-Induced Peripheral Neuropathy by Munawwar Abdulla Supervisor: Dr. Gila Moalem-Taylor Co-supervisor: Dr. Justin Lees Co-supervisor: Dr. Patsie Pollie August, 2018 i The University of New South Wales Thesis/Dissertation Sheet Surname or Family name: Abdulla First name/s: Munawwar Abbreviation for degree as given in the University calendar: MSc School: School of Medical Sciences Faculty: Medicine Title: Investigating neuroprotectants for the treatment of chemotherapy-induced peripheral neuropathy Abstract 350 words maximum: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and dose-limiting side effect of many chemotherapy regimens and is becoming a more prevalent issue as the longevity of cancer patients continues to increase. Sensory symptoms include neuropathic pain, paraesthesia, and numbness and usually spread in a glove-and-stocking distribution. At present, there are no effective medications to treat or prevent CIPN, and the mechanisms by which symptoms are induced have not been fully elucidated. Paclitaxel (PTX) is a commonly used chemotherapeutic that induces neuropathy in a high percentage of patients. The broad aim of this thesis was to establish a model of CIPN in vitro and in vivo and test clinically approved drugs for potential neuroprotective effects. Since the dorsal root ganglion (DRG) has been implicated in CIPN, we cultured dissociated primary DRG neurons from 5-week-old C57BL/6 mice and treated them with PTX to observe neurotoxic effects.
    [Show full text]
  • Ketamine Inhibits Lung Fluid Clearance Through Reducing Alveolar Sodium Transport
    Hindawi Publishing Corporation Journal of Biomedicine and Biotechnology Volume 2011, Article ID 460596, 6 pages doi:10.1155/2011/460596 Research Article Ketamine Inhibits Lung Fluid Clearance through Reducing Alveolar Sodium Transport Yong Cui,1 Hongguang Nie,2 Hong Ma,1 Lei Chen,3 Lin Zhang,4 Junke Wang,1 and Honglong Ji5 1 Department of Anesthesiology, First Affiliated Hospital, China Medical University, Shenyang 110001, China 2 Institute of Metabolic Disease Research and Drug Development, China Medical University, Shenyang 110001, China 3 School of Pharmaceutical Sciences, China Medical University, Shenyang 110001, China 4 Department of Thoracic Surgery, First Affiliated Hospital, China Medical University, Shenyang 110001, China 5 Department of Biochemistry, University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA Correspondence should be addressed to Yong Cui, [email protected] Received 28 May 2011; Revised 13 July 2011; Accepted 1 August 2011 Academic Editor: Daniel T. Monaghan Copyright © 2011 Yong Cui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Ketamine is a broadly used anaesthetic for analgosedation. Accumulating clinical evidence shows that ketamine causes pulmonary edema with unknown mechanisms. We measured the effects of ketamine on alveolar fluid clearance in human lung lobes ex vivo. Our results showed that intratracheal instillation of ketamine markedly decreased the reabsorption of 5% bovine serum albumin instillate. In the presence of amiloride (a specific ENaC blocker), fluid resolution was not further decreased, suggesting that ketamine could decrease amiloride-sensitive fraction of AFC associated with ENaC.
    [Show full text]
  • Amiloride Hydrochloride and Hydrochlorothiazide Tablets USP
    AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE- amiloride hydrochloride and hydrochlorothiazide tablet Teva Pharmaceuticals USA, Inc. ---------- Amiloride Hydrochloride and Hydrochlorothiazide Tablets USP 5 mg/50 mg Rx only DESCRIPTION Amiloride Hydrochloride and Hydrochlorothiazide Tablets USP combine the potassium-conserving action of amiloride hydrochloride with the natriuretic action of hydrochlorothiazide. Amiloride HCl, USP is designated chemically as N-amidino-3,5,-diamino-6-chloropyrazine- carboxamide monohydrochloride dihydrate and its structural formula is: C6H8CIN7O•HCl•2H2O M.W. 302.12 Hydrochlorothiazide, USP is designated chemically as 6-chloro-3,4-dihydro-2H-1, 2, 4-benzo- thiadiazine-7-sulfonamide 1, 1-dioxide. Its structural formula is: C7H8CIN3O4 S2 M.W. 297.74 It is a white, or practically white, crystalline powder which is slightly soluble in water, but freely soluble in sodium hydroxide solution. Each tablet, for oral administration, contains 5 mg of amiloride hydrochloride, USP (calculated on the anhydrous basis) and 50 mg of hydrochlorothiazide, USP. Inactive Ingredients: Croscarmellose sodium, D&C yellow no. 10 (aluminum lake), lactose monohydrate, magnesium oxide, magnesium stearate, microcrystalline cellulose. CLINICAL PHARMACOLOGY Amiloride hydrochloride and hydrochlorothiazide tablets provide diuretic and antihypertensive activity (principally due to the hydrochlorothiazide component), while acting through the amiloride component to prevent the excessive potassium loss that may occur in patients receiving a thiazide diuretic. Due to its amiloride component, the urinary excretion of magnesium is less with amiloride and hydrochlorothiazide than with a thiazide or loop diuretic used alone (see PRECAUTIONS). The onset of the diuretic action of this product is within 1 to 2 hours and this action appears to be sustained for approximately 24 hours.
    [Show full text]
  • Using Medications, Cosmetics, Or Eating Certain Foods Can Increase Sensitivity to Ultraviolet Radiation
    USING MEDICATIONS, COSMETICS, OR EATING CERTAIN FOODS CAN INCREASE SENSITIVITY TO ULTRAVIOLET RADIATION. INDIVIDUALS SHOULD CONSULT A PHYSICIAN BEFORE USING A SUNLAMP, IF THEY ARE TAKING MEDICATIONS. THE ITEMS LISTED ARE POTENTIAL PHOTOSENSITIZING AGENTS THAT MAY INCREASE SENSITIVITY TO ULTRAVIOLET LIGHT THAT MAY RESULT IN A PHOTOTOXIC OR PHOTOALLERGIC RESPONSES. PHOTOSENSITIZING MEDICATIONS Acetazolamide Amiloride+Hydrochlorothizide Amiodarone Amitriptyline Amoxapine Astemizole Atenolol+Chlorthalidone Auranofin Azatadine (Optimine) Azatidine+Pseudoephedrine Bendroflumethiazide Benzthiazide Bromodiphenhydramine Bromopheniramine Captopril Captopril+Hydrochlorothiazide Carbaamazepine Chlordiazepoxide+Amitriptyline Chlorothiazide Chlorpheniramine Chlorpheniramin+DPseudoephedrine Chlorpromazine Chlorpheniramine+Phenylopropanolamine Chlorpropamide Chlorprothixene Chlorthalidone Chlorthalidone+Reserpine Ciprofloxacin Clemastine Clofazime ClonidineChlorthalisone+Coal Tar Coal Tar Contraceptive (oral) Cyclobenzaprine Cyproheptadine Dacarcazine Danazol Demeclocycline Desipramine Dexchlorpheniramine Diclofenac Diflunisal Ditiazem Diphenhydramine Diphenylpyraline Doxepin Doxycycline Doxycycline Hyclate Enalapril Enalapril+Hydrochlorothiazide Erythromycin Ethylsuccinate+Sulfisoxazole Estrogens Estrogens Ethionamide Etretinate Floxuridine Flucytosine Fluorouracil Fluphenazine Flubiprofen Flutamide Gentamicin Glipizide Glyburide Gold Salts (compounds) Gold Sodium Thiomalate Griseofulvin Griseofulvin Ultramicrosize Griseofulvin+Hydrochlorothiazide Haloperidol
    [Show full text]
  • Stembook 2018.Pdf
    The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]